The companion diagnostics market was estimated at USD 6.69 billion in 2022 and is likely to grow at a CAGR of 11.99% during 2023-2028 to reach USD 13.55 billion in 2028.
Market Drivers:
These factors are expected to boost the demand for the global companion diagnostics market in the coming years:
Growing demand for personalized medicine: Companion diagnostics help physicians identify patients who are most likely to benefit from specific treatments, leading to better outcomes and reduced healthcare costs.
Increase in R&D of targeted therapies: Targeted therapies have become an important area of drug development, and companion diagnostics play a key role in identifying patients who are likely to respond to these therapies.